Willingness of Women with Endometriosis Planning to Undergo IVF to Participate in a Randomized Clinical Trial and the Effects of the COVID-19 Pandemic on Potential Participation

The Pre-IVF Treatment with a GnRH Antagonist in Women with Endometriosis (PREGnant) Trial (clinicaltrials.gov no. NCT04173169) was designed to test the hypothesis that 60-day pre-treatment with an oral GnRH antagonist in women with documented endometriosis and planning an IVF cycle will result in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pretzel, Shannon, Kuhn, Katherine, Pal, Lubna, Polotsky, Alex, Taylor, Hugh S., Zhang, Heping, Robins, Jared, Young, Steven L., Santoro, Nanette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Reproductive Endocrinology: Methodologies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345905/
https://www.ncbi.nlm.nih.gov/pubmed/34363198
http://dx.doi.org/10.1007/s43032-021-00705-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345905/
https://www.ncbi.nlm.nih.gov/pubmed/34363198
http://dx.doi.org/10.1007/s43032-021-00705-0

Ejemplares similares